Sbc Medical Group Holdings Incorporated
A medical services organization, SBC Medical Group backs a broad network of clinics across aesthetic medicine, dermatology, dentistry, fertility treatment, and more, handling branding, marketing, and operations so doctors can focus on care. It grew out of the Shonan Beauty Clinic, opened in 2000 by Dr. Yoshiyuki Aikawa in Fujisawa, Japan, and in 2024 became the first Japanese medical group listed on the U.S. Nasdaq. The name "SBC" survives from that first "Shonan Beauty Clinic" even though the group now spans far beyond beauty.
Class A Common Stock — Merged with SBC Medical Group Holdings on Sept 17, 2024; ticker changed to SBC on Sept 18, 2024
Sold 7.99M
Bought 164.5K · Sold 86.0K
Bought 634.4K
Bought 634.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Aikawa YoshiyukiChairman and CEO, Director, 10% owner · 4 transactions | — | 177.97M | — | — | 7.99M |
| Tomita Kazumasa +3 co-filers10% owner · 68 transactions | — | 5.68Mas of Sep 2024 | — | 164.5K | 86.0K |
| Mehana Capital LLC10% owner · 1 transaction | — | 634.4Kas of Aug 2022 | — | 634.4K | — |
| Shindo Dustin MDirector, 10% owner · 1 transaction | — | 634.4Kas of Aug 2022 | — | 634.4K | — |
| Sayama Mike KDirector · 1 transaction | — | 15.0Kas of Sep 2024 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -6.64M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.